Alere Inc. is withdrawing the Alere INRatio ® and INRatio ® 2 Prothrombin Time Monitoring Systems (professional and self-test) devices from the Canadian market. These devices measure blood clotting ...
Roche Diagnostics announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for the CoaguChek XS Pro system, a new point-of-care anticoagulation monitor with a ...
Alere has issued a voluntary correction to users of the Alere INRatio and INRatio 2 PT/INR Monitor system of certain medical conditions that should not be tested with the system (INRatio Monitor ...
INDIANAPOLIS, Nov. 11 The U.S. Food and DrugAdministration has granted approval for the new Handheld Base Unit for theCoaguChek(R) XS Plus System, which provides connectivity between ...
A concerned daughter brings her father to a hospital as her father noticed blood in his stools. He also had large bleeding patches on the back of the chest and thighs. She recalls that her father is ...
Concerned over nine serious adverse events, three of which described bleeding associated with patient deaths, Alere Inc. of Waltham, MA issued a voluntary urgent recall of its PN 99008G2 INRatio2 ...
Globally, how many patients are estimated to be taking Warfarin and what are the main reasons the drug is prescribed? There are roughly 10 million people worldwide taking Warfarin, accounting for more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback